Mint Tower Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Mint Tower Capital Management’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15,000	Closed	-$420K	–	479
2022 Q1	$420K	Sell	15,000 -26,302	-64%	-$721K	0.04%	246
2021 Q4	$1.13M	Buy	41,302 +20,100	+95%	+$545K	0.15%	130
2021 Q3	$577K	Buy	+21,202	New	+$524K	0.07%	194

Mint Tower Capital Management's XENT Position: Q2 2022 in Review

Mint Tower Capital Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 15,000 shares — an estimated $420K sold.

Mint Tower Capital Management first reported a position in XENT in Q3 2021 and held it in 3 quarters. The position peaked at $1.13M in Q4 2021. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

Mint Tower Capital Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
Mint Tower Capital Management sold 15,000 Intersect ENT, Inc shares in Q2 2022, an estimated $420K.
Mint Tower Capital Management first reported a position in Intersect ENT, Inc in Q3 2021 and held it in 3 quarters.
Mint Tower Capital Management's Intersect ENT, Inc position peaked at $1.13M in Q4 2021.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Mint Tower Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.